![](/img/cover-not-exists.png)
Ruxolitinib Therapy Followed by Reduced Intensity Conditioning for Hematopoietic Cell Transplantation for Myelofibrosis – Myeloproliferative Disorders Research Consortium 114 study
Gupta, Vikas, Kosiorek, Heidi E., Mead, Adam, Klisovic, Rebecca B, Galvin, John P., Berenzon, Dmitriy, Yacoub, Abdulraheem, Viswabandya, Auro, Mesa, Ruben A., Goldberg, Judith, Price, Leah, Salama, MoLanguage:
english
Journal:
Biology of Blood and Marrow Transplantation
DOI:
10.1016/j.bbmt.2018.09.001
Date:
September, 2018
File:
PDF, 985 KB
english, 2018